Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives

Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Despite significant efforts, no therapies have demonstrated valuable survival benefit beyond the current standard of care. Immune checkpoint inhibitors (ICI) have revolutionized the treatment landscape and improved...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Med
Hauptverfasser: Persico, Pasquale, Lorenzi, Elena, Dipasquale, Angelo, Pessina, Federico, Navarria, Pierina, Politi, Letterio S., Santoro, Armando, Simonelli, Matteo
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036455/
https://ncbi.nlm.nih.gov/pubmed/33810532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071367
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge